HUPERZINE OPTI-BRAIN (Capsule)

WHAT NOOLIT: HUPERZINE OPTI-BRAIN CONTAINS (COMPOSITION)

Each capsule contains:

Huperzia serrata (Huperzine A)
(herb, as 500 μg of an extract standardized to 99 %)
500 μg

Sugar free.

What is in this leaflet

  • What NOOLIT: HUPERZINE OPTI-BRAIN is and what it is used for
  • What you need to know before you take NOOLIT: HUPERZINE OPTI-BRAIN
  • How to take NOOLIT: HUPERZINE OPTI-BRAIN
  • Possible side effects
  • How to store NOOLIT: HUPERZINE OPTI-BRAIN
  • Contents of the pack and other information

    WHAT NOOLIT: HUPERZINE OPTI-BRAIN IS USED FOR
    NOOLIT: HUPERZINE OPTI-BRAIN aids with cognitive function and impaired concentration.

    What you need to know before you take NOOLIT: HUPERZINE OPTI-BRAIN

    Some medical conditions may interact with the product.
    Tell your doctor or pharmacist if you are taking any other medications.
    Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

    • if you are pregnant, planning to become pregnant, or are breast-feeding
    • if you have allergies to medicines, foods, or other substances

    Do not take NOOLIT: HUPERZINE OPTI-BRAIN

    • If you are hypersensitive (allergic) to Huperzia serrata (see section “WHAT NOOLIT: HUPERZINE OPTI-BRAIN CONTAINS”).
    • If you are under the age of 18 years old.
    • Contact your doctor or pharmacist right away if this applies to you.

    Taking other medicines with NOOLIT: HUPERZINE OPTI-BRAIN

    • The effect of other medication and NOOLIT: HUPERZINE OPTI-BRAIN is not known.
    • Ask your doctor or pharmacist if this product may interact with other medicines that you take.
    • Check with your doctor or pharmacist before you start, stop, or change the dose of any medicine.
    • Consult a doctor or pharmacist before using the product, if on any prescribed medication.

    Taking NOOLIT: HUPERZINE OPTI-BRAIN with food and drink
    NOOLIT: HUPERZINE OPTI-BRAIN can be taken after consumption of food.

    Pregnancy and Lactation
    The safety of this product in human pregnancy has not been established.
    Do not take NOOLIT: HUPERZINE OPTI-BRAIN if you are breast-feeding your baby.

    Driving and using machines
    NOOLIT: HUPERZINE OPTI-BRAIN does not cause drowsiness; however, as with any new medicine you should take care while driving or using machinery until you know how it affects you.

    HOW TO TAKE NOOLIT: HUPERZINE OPTI-BRAIN
    Do not share medicines prescribed for you with any other person.
    In the event of over dosage, consult your doctor or pharmacist.
    If neither is available, contact the nearest hospital or poison control center.

    How much to take
    Adults: Take 1 capsule once a day before meals to aid with cognitive function and impaired concentration. Can be used twice daily.
    DO NOT EXCEED THE MAXIMUM RECOMMENDED INTAKE OF 2 CAPSULES PER DAY.
    Use as only as directed by your doctor or pharmacist.

    If you take more NOOLIT: HUPERZINE OPTI-BRAIN than you should
    If you take more than the prescribed dose of NOOLIT: HUPERZINE OPTI-BRAIN, contact your Doctor or Pharmacist, or nearest hospital emergency department or poison control center immediately. Do this even if there are no signs of discomfort.
    If you forget to take NOOLIT: HUPERZINE OPTI-BRAIN
    If you forget to take a dose, take it as soon as you remember, and then continue as before.
    Do not take a double dose to make up for forgotten individual doses.

    Possible Side Effects
    NOOLIT: HUPERZINE OPTI-BRAIN can cause side effects.
    Not all side effects reported for this medicine are included in this leaflet. Should your general health worsen while taking this medicine, please consult your doctor or pharmacist for advice.
    All medicines may cause side effects, but many people have no, or minor, side effects
    Do not exceed recommended dosage unless otherwise prescribed by your doctor or pharmacist.
    NOOLIT: HUPERZINE OPTI-BRAIN may cause the following side effects:
    nausea (probably due to a secondary dopaminergic activation) and this may require dosage reduction

    • diarrhea
    • vomiting
    • dry mouth
    • constipation
    • sweating
    • blurred vision
    • slurred speech
    • fainting
    • loss of appetite
    • cramping
    • inability to control urination
    • high blood pressure
    • dizziness
    • slowed heart rate
    • inflammation of the stomach,
    • problems with your gut
    • drowsiness
    • sleeplessness; trouble sleeping;
    • unable to sleep
    • nervousness
    • convulsion
    • increase in body movements.

    Seek medical attention right away if any of these severe side effects occur: (You may need urgent medical attention or hospitalization.) Tell your doctor immediately if you experience any of the following side-effects, or go to the hospital straight away.

    HOW TO STORE NOOLIT: HUPERZINE OPTI-BRAIN
    STORE ALL MEDICINE OUT OF REACH OF CHILDREN.

    • Store in a cool, dry place below 25 °C.
    • Protect from light.
    • Keep the container tightly closed.
    • Do not store in a bathroom.
    • Do not use after the expiry date stated on the label/carton/bottle.
    • Check with your pharmacist about how to dispose safely of unused medicine.
    • Do not dispose of unused medicine in drains or sewerage systems (e.g toilets)
    • Return all unused medicine to your pharmacist.

    What NOOLIT: HUPERZINE OPTI-BRAIN looks like and contents of the pack
    NOOLIT: HUPERZINE OPTI-BRAIN capsules are white bovine gelatine capsule

    IDENTIFICATION OF NOOLIT: HUPERZINE OPTI-BRAIN
    NOOLIT: HUPERZINE OPTI-BRAIN is packaged in a white pet bottle with heat seal
    and a white safety screw top lid.

    REGISTRATION NUMBER
    To be allocated

    NAME AND BUSINESS ADDRESS OF THE APPLICANT
    XS PHARMA (Pty) Ltd
    The Innovation Hub
    1 Mark Shuttleworth St
    Lynwood
    Pretoria
    0087

    DATE OF PUBLICATION OF THE PACKAGE INSERT
    October 2021

    CATEGORY D
    D. 33.4 Traditional Chinese Medicine, Complementary Medicines: Discipline-specific medicine.
    This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. Intended to only complement the health or supplement the diet.